Xylem (XYL) Research & Development (2010 - 2026)

Xylem's Research & Development history runs 17 years deep, the most recent figure standing at $56.0 million for Q1 2026.

• In Q1 2026, Research & Development changed 0.0% year-over-year to $56.0 million; the TTM figure through Mar 2026 stood at $226.0 million (changed 0.44% YoY), while the FY2025 annual figure was $226.0 million, down 1.74% from the prior year.
• Research & Development was $56.0 million for Q1 2026 at Xylem, down from $60.0 million in the prior quarter.
• In the past five years, Research & Development ranged from a high of $61.0 million in Q3 2023 to a low of $47.0 million in Q3 2022.
• Historically, Research & Development has averaged $55.9 million across 5 years, with a median of $56.0 million in 2025.
• The sharpest annual moves came in 2023 and 2024: Research & Development rose 29.79% in 2023, then slipped 9.84% in 2024.
• A 5-year view of Research & Development shows it stood at $54.0 million in 2022, then gained by 11.11% to $60.0 million in 2023, then retreated by 3.33% to $58.0 million in 2024, then increased by 3.45% to $60.0 million in 2025, then dropped by 6.67% to $56.0 million in 2026.
• The last three Research & Development figures came in at $56.0 million (Q1 2026), $60.0 million (Q4 2025), and $52.0 million (Q3 2025), per Business Quant data.